MedPath

The Utility of Thromboelastography in Cirrhotic Patients Undergoing Endoscopic Procedures

Not Applicable
Terminated
Conditions
Cirrhosis, Coagulopathy
Interventions
Biological: Blood transfusion
Registration Number
NCT02990273
Lead Sponsor
Johns Hopkins University
Brief Summary

Cirrhosis results in decreased synthesis of both procoagulants and anticoagulants resulting in "rebalanced homeostasis". However, conventional blood tests (platelets/ INR levels) that are performed prior to invasive procedures do not accurately reflect the coagulation changes that occur in cirrhotics, resulting in unnecessary transfusion of blood products. Thromboelastography (TEG) is a global hemostasis assessment tool that is being used in surgery (including liver transplant) to help guide blood product transfusion in the operating room. The investigators would like to compare the use of TEG vs. INR/platelets to help guide blood product transfusion in cirrhotic patients undergoing inpatient endoscopy. The investigators will evaluate to see if there is a decrease in prophylactic blood transfusions prior to endoscopy when using TEG.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1
Inclusion Criteria
  • All 18 yo + cirrhotic patients who are being scheduled for inpatient endoscopy
Exclusion Criteria
  • Patients on blood thinners (prophylactic anticoagulation is permissible)
  • Hemodynamically unstable patients requiring pressors (ie ICU level patients)
  • Pregnant or lactating individuals
  • Inability to provide consent for any reason

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TEGBlood transfusionBlood transfusion
Prothrombin Time (PT)/International normalized ratio (INR)Blood transfusionBlood transfusion
Primary Outcome Measures
NameTimeMethod
Units of fresh frozen plasma (FFP) and platelet transfused2 week

Will compare how much FFP and platelet transfusion patients receiving between 2 groups.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath